JMI Hospital Requisite Manufacturing Ltd

JMI Hospital Requisite Manufacturing Ltd maintains a strong liquidity position, with a current ratio of 3.08, indicating the company can cover its short-term liabilities more than three times over. However, the company's net cash position is negative after subtracting total debt, signaling potential liquidity risk. The company's debt-to-equity ratio of 0.27 suggests a conservative capital structure, with equity significantly outweighing debt.

In terms of profitability, the company's return on equity (ROE) of 1.88% and return on assets (ROA) of 1.41% are below the industry median for medical equipment and supplies firms, indicating subpar efficiency in generating returns from equity and total assets. The net income of 78.35 million BDT and operating income of 109.88 million BDT reflect a stable but modest profit margin, with gross profit of 144.30 million BDT on total revenue of 448.69 million BDT.

The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic or regulatory shifts, particularly in the healthcare sector. The absence of segment or geographic breakdown in the financial data limits the ability to assess risk and growth potential across different markets.

Looking ahead, the company's growth trajectory is constrained by its current financial performance and capital structure. The capital expenditure of -59.82 million BDT indicates a reduction in investment in new assets, which may limit future growth. The free cash flow of 73.62 million BDT and operating cash flow of 133.78 million BDT suggest the company is generating positive cash from operations, but the lack of significant reinvestment may hinder long-term expansion.

The risk assessment highlights a medium liquidity risk and low dilution risk. The company's net cash is negative after subtracting total debt, which could pressure liquidity if short-term obligations increase. However, the dilution risk is low, with no near-term pressure from share issuance or dilutive events. The company's conservative debt levels and strong equity position reduce the likelihood of dilution in the near term.

Recent filings and transcripts do not indicate any major strategic shifts or significant events that would alter the company's current trajectory. The company appears to be maintaining a stable but low-growth business model, with no disclosed plans for expansion or diversification.

Cash conversion ratio of 1.71 is well above the cohort median of 0.84, reflecting robust cash generation capabilities.

Debt-to-equity ratio of 0.27 is below the cohort median of 0.20, suggesting a conservative leverage profile compared to peers.

Return on equity of 1.88% slightly outperforms the cohort median of 1.42%, indicating modestly better capital efficiency.

The company faces high credit risk, which could impair financial stability or increase borrowing costs in the future.

Medium liquidity risk flags potential challenges in meeting short-term obligations or managing cash flow volatility.